ArticleJournal of Cancer2020

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-Muscle Invasive Bladder Cancer in the Han Chinese Population.

Zhiyong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.